๐ ๐ผ๐ป๐ถ๐๐ผ๐ฟ๐ถ๐ป๐ด ๐๐๐๐ฉ ๐ผ๐๐๐ฏ๐ฟ๐ฒ๐ฎ๐ธ๐ As Epizootic Hemorrhagic diseaseย is currently ๐๐ฝ๐ฟ๐ฒ๐ฎ๐ฑ๐ถ๐ป๐ด ๐๐ฒ๐ฟ๐ ๐ณ๐ฎ๐๐ ๐ถ๐ป ๐ฆ๐ผ๐๐๐ต๐ฒ๐ฟ๐ป ๐๐๐ฟ๐ผ๐ฝ๐ฒ, close monitoring may be performed using ๐๐ฒ๐ฟ๐ผ๐น๐ผ๐ด๐ถ๐ฐ๐ฎ๐น ๐๐ฒ๐๐๐. ย To this end, ๐๐ ๐ฆ๐ฐ๐ฟ๐ฒ๐ฒ๐ปยฎ ๐๐๐๐ฉ ๐ฐ๐ผ๐บ๐ฝ๐ฒ๐๐ถ๐๐ถ๐ผ๐ป is a highly reliable and performant ELISA, allowing for the detection of antibodies directed against EHDV ๐ถ๐ป ๐ฑ๐ผ๐บ๐ฒ๐๐๐ถ๐ฐ ๐ฎ๐ป๐ฑ ๐๐ถ๐น๐ฑ ๐ฟ๐๐บ๐ถ๐ป๐ฎ๐ป๐๐. ย The test provides: โ An efficient detection of ๐ฎ๐น๐น ๐๐๐๐ฉ ๐๐ฒ๐ฟ๐ผ๐๐๐ฝ๐ฒ๐ โ ๐ฅ๐ฒ๐น๐ถ๐ฎ๐ฏ๐น๐ฒ ๐ฟ๐ฒ๐๐๐น๐๐ thanks to excellent diagnostic sensitivity and specificity โ ๐๐ป ๐ฒ๐ ๐ฐ๐น๐๐๐ถ๐๐ฒ ๐ฑ๐ฒ๐๐ฒ๐ฐ๐๐ถ๐ผ๐ป ๐ผ๐ณ ๐๐ต๐ฒ ๐๐๐ ๐๐ถ๐ฟ๐๐ due to the absence of cross-reactivity with the Bluetongue virus ย ๐ ๐ฅ๐ฒ๐ฎ๐ฐ๐ต ๐ผ๐๐ ๐๐ผ ๐ฟ๐ฒ๐พ๐๐ฒ๐๐ ๐๐ต๐ฒ ๐๐ฎ๐น๐ถ๐ฑ๐ฎ๐๐ถ๐ผ๐ป ๐ฟ๐ฒ๐ฝ๐ผ๐ฟ๐ of the test, including all performance data. ย #EHDV #EpizooticDisease #Serology #ELISA #IDvet #InnovativeDiagnostics
IDvetโs Post
More Relevant Posts
-
This white paper summarizes a webinar hosted by Nature Research Custom Media and sponsored by Thermo Fisher Scientific in which the speakers discussed using fragment analysis for the multiplexed identification of viruses and bacteria, focusing on applications for artificial joint infections, inflammatory bowel disease, and improving in vitro fertilization success rates. #fragmentanalysis #CE #thermofisheremp
To view or add a comment, sign in
-
Researchers at Massachusetts General Hospital (MGH) have discovered a protein called NLRP11 that plays a crucial role in the body's immune response to bacterial infections. When certain bacteria are ingested by immune cells, NLRP11 recognizes them through their outer coat, activating an immune defense against the invasion. NLRP11 is present in humans but not in mice, the common laboratory model for human infection, which could help improve mouse models for studying infections and immune-related diseases. The discovery opens new avenues for understanding the immune system's response to bacterial invaders. Read more: https://lnkd.in/dJhDxXQu #medicalscience #immunesystem #infection #biology #lifescience
To view or add a comment, sign in
-
A group of PRC researchers just published that they have mutated the Cov-2/Covid-19 virus, to make a supposedly 100% lethal virus. Which is much higher than the currect Covid-19 lethality rate. โAbstract SARS-CoV-2-related pangolin coronavirus GX_P2V(short_3UTR) can cause 100% mortality in human ACE2-transgenic mice, potentially attributable to late-stage brain infection. This underscores a spillover risk of GX_P2V into humans and provides a unique model for understanding the pathogenic mechanisms of SARS-CoV-2-related viruses.โ As I wrote about in The Wall Street Journal last year, Chinese research is generating these types of viruses, including their publicly self-announced military applications of gene editing. https://lnkd.in/gqGGcPDS https://lnkd.in/gqEBRHtV
Lethal Infection of Human ACE2-Transgenic Mice Caused by SARS-CoV-2-related Pangolin Coronavirus GX_P2V(short_3UTR)
biorxiv.org
To view or add a comment, sign in
-
Adjunct Assistant Professor in Electrical and Computer Engineering (ECE) at Georgia Institute of Technology
NLRP11 is a pattern recognition receptor for bacterial lipopolysaccharide in the cytosol of human macrophages https://lnkd.in/g2Km3Tfw
Researchers at Massachusetts General Hospital (MGH) have discovered a protein called NLRP11 that plays a crucial role in the body's immune response to bacterial infections. When certain bacteria are ingested by immune cells, NLRP11 recognizes them through their outer coat, activating an immune defense against the invasion. NLRP11 is present in humans but not in mice, the common laboratory model for human infection, which could help improve mouse models for studying infections and immune-related diseases. The discovery opens new avenues for understanding the immune system's response to bacterial invaders. Read more: https://lnkd.in/dJhDxXQu #medicalscience #immunesystem #infection #biology #lifescience
To view or add a comment, sign in
-
Discover the latest innovations in DNA & RNA technologies on April 16th 2024. This inspiring day shows all the latest developments in a fast-changing industry and demonstrates the impact of DNA research on people and plants. The day is filled with interesting lectures, practical solutions and a lot of knowledge. Prof. dr. John Rossen will explore the power of advanced technologies and machine learning in the diagnosis, prevention, and combat of infectious diseases. He will explain how these techniques contribute to infection prevention. And he will discuss how (personalized) molecular diagnostics, which detect the DNA/RNA of pathogens, can lead to faster and more accurate diagnoses. Check the complete program and register via the website: https://hubs.li/Q02lVxR-0 #laboratoriumtechnologie #FHI #Lifescience
To view or add a comment, sign in
-
Scientist D, Bhabha Atomic Research Centre | Bacteriophage Researcher | Microbiologist | Mentor | Biofilm | Biofouling | Bacterial Collection | Antimicrobial Resistance | Phage Bank | Phage Advocacy, Learner, and Speaker
Phage genomes integrated within bacterial genomes, or prophages, often carry genes that defend against further phage attacks. These genes typically operate at the cell surface, blocking phages from binding to their host receptor. The recent discovery of prophage-encoded proteins similar to FimU, a Pseudomonas aeruginosa type IV pilus component, has shed light on a fascinating phage defence mechanism. These phage-derived FimU proteins seamlessly integrate into the pilus structure without disrupting its normal function. However, their presence confers significant protection against phage infections that target the pilus tip, where FimU is believed to be situated. The diversity observed in the phage FimU proteins and the phage tail proteins interacting with FimU hints at a complex evolutionary arms race driven by phage-to-phage competition. This dynamic interplay underscores the adaptability of phages and the ingenious strategies bacteria employ to fend off viral threats. The ability of phages to evolve rapidly and develop countermeasures against bacterial defences underscores the continuous battle for survival at the microscopic level. This groundbreaking discovery represents a novel example of anti-phage defence tactics, showcasing how bacteria can repurpose a surface component with a phage-derived protein to bolster their immunity. The intricate molecular ballet between phages and bacteria highlights the perpetual struggle for dominance in the microbial world. The findings open new avenues for research into the intricate mechanisms underlying phage-host interactions and offer a glimpse into the fascinating world of microbial warfare. https://buff.ly/3TY2d10
Prophages express a type IV pilus component to provide anti-phage defence
biorxiv.org
To view or add a comment, sign in
2,120 followers